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Abstract 
Development of a mental health education package for community pharmacy staff should be 
informed by mental health consumers/carers’ needs, expectations and experiences, and staff 
knowledge, skills and attitudes.  This review 1) explored research on community pharmacy 
practice and service provision for mental health consumers/carers, and 2) identified validated 
methods for assessing staff knowledge, skills and attitudes about mental illness to inform the 
development of a training questionnaire.  A literature scan using key words knowledge, skills, 
attitudes and beliefs combined with community pharmacy, pharmacist, and pharmacy support 
staff, and mental illness, depression, anxiety was conducted.  A small number of studies were 
found that used reliable methods to assess pharmacists’ training needs regarding mental 
illness and treatment options.  There was little published specifically in relation to depression 
and anxiety in community pharmacy practice.  No studies assessed the training needs of 
pharmacy support staff.  A systematic analysis of pharmacy staff learning needs is warranted.    
Mental Health Educational Needs of Pharmacy Staff  4 
 
Introduction 
Globally, mental illness is common affecting one person in four at some stage of their 
lifetime (World Health Organization, 2001).  Depression is a major contributor to the global 
burden of disease;  in third place worldwide and first place in middle to high-income 
countries (World Health Organization, 2008a).  In Australia, mental illness is the largest 
single cause of disability, accounting for nearly 30% of the burden of non-fatal disease 
(Mental Health Branch Queensland Health, 2008).  Nearly half (45.5%) of all Australians 
aged between 16-85 years will experience a mental illness over their lifetime (Slade, 
Johnston, Oakley Browne, Andrews, & Whiteford, 2009).  A national survey of mental health 
and wellbeing conducted in 2007 revealed one in five Australians aged between 16-85 years 
had been affected by mental illness at some time during the previous 12 months.  Anxiety-
related disorders were the most common (14.4% 12 month prevalence) followed by mood 
disorders (such as depression) with 6.2% 12 month prevalence (Slade, et al., 2009).   
A number of studies have sought to gain a better understanding of public perceptions 
of mental illness, by assessing community knowledge, beliefs and attitudes towards people 
who experience mental illness (Angermeyer & Dietrich, 2006; Angermeyer & Matschinger, 
2003; Corrigan & Watson, 2002; Crisp & Gelder, 2000; Jorm, Korten, Jacomb, Christensen, 
& Henderson, 1999; Kai & Crosland, 2001; Kobau, Dilorio, Chapman, Delvecchio, & 
Members, 2010; Link, Cullen, Frank, & Wozniak, 1987; Scheerder et al., 2011; Wahl, 1999).  
These studies highlight that although the public’s ability to recognise mental illness in 
general is good, stigmatising opinions about people experiencing mental illness are common.  
These stigmatising views include the belief that some mental disorders are self-inflicted, 
stress is commonly endorsed as the cause, people with a mental illness are perceived as being 
hard to talk to, and are likely to display violent behaviour (Angermeyer & Dietrich, 2006; 
Angermeyer & Matschinger, 2003; Corrigan & Watson, 2002; Crisp & Gelder, 2000; Jorm, 
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et al., 1999; Kai & Crosland, 2001; Kobau, et al., 2010; Link, et al., 1987; Scheerder, et al., 
2011; Wahl, 1999).  Furthermore, members of the public have expressed a desire to maintain 
social distance from those with mental health problems (Angermeyer & Dietrich, 2006; 
Angermeyer & Matschinger, 2003; Corrigan & Watson, 2002; Crisp & Gelder, 2000; Jorm, 
et al., 1999; Link, et al., 1987; Wahl, 1999).  In addition to social isolation, distress and 
workplace problems, several researchers conclude that the public’s lack of accurate 
knowledge and negative attitudes and beliefs contribute to the difficulties faced by people 
who live with mental illness (Angermeyer & Dietrich, 2006; Corrigan & Watson, 2002; Crisp 
& Gelder, 2000; Jorm, et al., 1999; Kai & Crosland, 2001; Wahl, 1999; World Health 
Organization, 2001).  Stigmatising attitudes and beliefs are also held by health professionals 
and can affect the way they provide care and services to consumers (Jorm, et al., 1999; Nordt, 
Rossler, & Lauber, 2006; Phokeo, Sproule, & Raman-Wilms, 2004; Scheerder, De Coster, & 
Van Audenhove, 2008; Scheerder, De Coster, & Van Audenhove, 2009; Scheerder, et al., 
2011; Volmer, Maesalu, & Bell, 2008; Wahl, 1999).   
Over the past three decades the global promotion of deinstitutionalisation has shifted 
the emphasis on mental health care and management from hospitals/institutions to the 
community, with the goal of avoidaning hospitalisation whenever possible (World Health 
Organization, 2008a, 2008b).  The past few decades have also seen an increase in the 
availability of pharmacological agents to treat mental illness, particularly newer classes of 
antidepressants with better safety and tolerability profiles (Mant et al., 2004).  Between 2008 
and 2009, 21.4 million prescriptions for mental health-related medicines were subsidised by 
the Australian government at an estimated cost of $743 million for the one year period 
(Australian Institute of Health and Welfare, 2010b). Australian pharmaceutical industry data 
show that between 1990 and 2002, antidepressant prescribing increased by 352%, with an 
average annual sales growth of 13.4% (Mant, et al., 2004).  More recent figures revealed that 
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between 2008 and 2009, 12.3 million prescriptions were written for antidepressants 
(Australian Institute of Health and Welfare, 2010a).  This represents a significant investment 
made by the Australian Government to improve health outcomes and quality of life for 
people with mental illness.   
Optimal treatment of mental illness focuses on both symptom and functional recovery 
with a range of pharmacological, psychosocial and psychological interventions (Mental 
Health Commission, 2004; World Health Organization, 2008c).  Although the appropriate use 
of medication is an integral part of effective management, medicines are often used sub-
optimally (Healthcare Management Advisors, 2010; Lingam & Scott, 2002; Meagher & 
Moran, 2003).  Factors contributing to suboptimal medication use relate to psychosocial 
difficulties, side effects of the medication and/or delayed onset of action, and such factors 
may further complicate treatment adherence for these enduring conditions (Lingam & Scott, 
2002; World Health Organization, 2001, 2008a, 2008b).  As medication experts, pharmacists 
are well positioned to support consumers, carers and other health professionals with the 
medication management of mental illness.  
 
Methods 
As part of a large scale longitudinal intervention study, a systematic assessment of the 
needs, expectations and experiences of mental health consumers/carers along with the 
knowledge, skills and attitudes of pharmacy staff is warranted.  Therefore, to inform the 
development of education and training materials for community pharmacy staff, this review 
aimed to: 1) explore existing work on community pharmacy practice and service provision 
for mental health consumers/carers, and 2) identify validated methods for assessing staff 
knowledge, skills and attitudes about mental illness, treatment, and interactions with 
Mental Health Educational Needs of Pharmacy Staff  7 
 
consumers/carers.  A literature scan using the key words knowledge, skills, and attitudes, 
beliefs combined with community pharmacy, pharmacist, and pharmacy support staff, and 
mental illness, depression, anxiety was conducted in the beginning of 2012.  A small number 
of studies were found that used a combination of well established, reliable methods to assess 
knowledge, skills, attitudes and beliefs of pharmacists about mental disorders and treatment 
options.  These studies are reviewed here in more detail.  The Human Research Ethics 
Committee of Griffith University approved this study (approval reference: 
PHM/13/11/HREC).  There are no known conflicts of interest.  All authors certify their 
responsibility for this manuscript.   
 
Results 
The Role of Community Pharmacy 
Australia has a network of over 5000 community pharmacies, staffed by trained 
professionals to deliver health care services to the public (Pharmacy Guild of Australia, 
2010).  As primary care providers, community pharmacy staff are involved in health 
promotion, early intervention, prevention, assessment and general management of 
consumers’ health and are often the first point of contact between consumers and the health 
care system (Pharmacy Guild of Australia, 2010).  Typically, the Australian community 
pharmacy workforce consists of pharmacists, pharmacy (dispensary) assistants and other staff 
involved in retail aspects of the business.  Internationally these support staff may be referred 
to as pharmacy or dispensary technicians, or other terminology may be used, but for the 
purposes of this review we have referred to these personnel as pharmacy support staff.  
Members of pharmacy support staff are involved in working with consumers and their role is 
to professionally and confidently provide advice and support on a variety of health, personal 
care, and beauty issues (Pharmacy Guild of Australia, 2012).  They deal with all aspects of 
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community pharmacy business which include everything from accepting prescriptions, 
providing health advice and assistance with the selection of non-prescription medicines under 
a pharmacists supervision.   
An overview of community pharmacy practice in Australia showed that people 
perceived pharmacists as “highly reliable advisers on many personal health matters, 
trustworthy independent purveyors of health care products”, and “steadfast partners of the 
medical profession” (Benrimoj & Frommer, 2004, p 238).  Accessibility to health care is 
enhanced not only by the extensive distribution of community pharmacies across the country, 
but also because people can visit a pharmacy without an appointment, speak with a health 
professional almost immediately, and retain a high level of control over the extent of their 
engagement with the staff (Benrimoj & Frommer).   
A recent large Australian study of consumer needs, experiences and expectations of 
community pharmacy found that consumers described community pharmacy as a more 
relaxed place than their doctor's surgery, and this provided an opportunity to obtain 
information about their treatment, condition and other services (University of South 
Australia, 2005).  The study also identified that consumers perceived pharmacists as medicine 
experts and that pharmacists used more consumer-friendly language than doctors when 
providing treatment information.  Although these findings provide valuable insight into 
consumer views, the authors also identified that mental health consumers may have different 
needs, expectations and experiences. 
To optimise treatment outcomes for people affected by mental illness, health 
professionals need to provide collaborative and integrated care which supports the recovery 
process (Bell, Rosen, Aslani, Whitehead, & Chen, 2007; Gilbert, Roughead, Beilby, Mott, & 
Barratt, 2002; Gilbody, Bower, Fletcher, Richards, & Sutton, 2006; Hammond et al., 2003; 
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Healthcare Management Advisors, 2010; World Health Organization, 2008b).  Several 
conditions facilitate the effective participation of pharmacists as part of a collaborative care 
team namely: a collaborative practice environment, a defined level of education, training, 
knowledge, skills and abilities, documentation of clinical activities, and financial 
compensation (Hammond, et al., 2003).  However, only a small number of studies have 
explored the role of community pharmacists within the collaborative care model (e.g., Bell, et 
al., 2007; Gilbert, et al., 2002; Gilbody, et al., 2006; Hammond, et al., 2003; Tanskanen, 
Airaksinen, Tanskanen, & Enlund, 2000).  An early Australian intervention involving 
community pharmacist-general practitioner collaborative practice found that home medicines 
review (HMR) resulted in improved management of medication-related problems and 
improved health outcomes for consumers (Gilbert, et al., 2002).  The authors argued that 
collaborative HMR services could particularly benefit at-risk groups such as people with 
chronic conditions, for example mental illness.  This collaborative care model is now well 
developed in Australia (Pharmacy Guild of Australia, 2010).  Pilot studies in the United 
Kingdom and Australia indicate that pharmacists’ medication reviews for consumers 
receiving care from community mental health services provide clinically appropriate 
recommendations that were likely to improve outcomes (Ewan & Greene, 2001; Gisev, Bell, 
O'Reilly, Rosen, & Chen, 2010; Harris & Anderson, 2003).  However, no published empirical 
work was found evaluating the impact of such a collaborative practice model for the routine 
management of mental illness. 
Impact of Community Pharmacy on Health Outcomes 
There is a large body of evidence to support the overall positive impact that 
pharmacist interventions can have on consumer and health care outcomes (Adler et al., 2004; 
Bell, McLachlan, Aslani, Whitehead, & Chen, 2005; Brook, Stalman, Nieuwenhuyse, 
Bakker, & de Haan, 2005; Brook, Van Hout, Nieuwenhuyse, & De Haan, 2003; Chong, 
Mental Health Educational Needs of Pharmacy Staff  10 
 
Aslani, & Chen, 2011; Ewan & Greene, 2001; George, Molina, Cheah, Chan, & Lim, 2010; 
Gilbert, et al., 2002; Gilbody, et al., 2006; Gisev, et al., 2010; Hammond, et al., 2003; 
Pharmacy Guild of Australia, 2010; Valenstein et al., 2011; Van Wijk, Klungel, Heerdink, & 
de Boer, 2005).  Specifically within the community pharmacy setting, consumer groups who 
have been shown to benefit include people with chronic conditions such as cardiovascular 
disease, asthma, diabetes mellitus, as well as consumers with other physical conditions (Bell, 
et al., 2005; George, et al., 2010; Gilbert, et al., 2002; Gilbody, et al., 2006; Hammond, et al., 
2003; Pharmacy Guild of Australia, 2010; Van Wijk, et al., 2005).  Pharmacists have also 
been involved in the monitoring of anticoagulation therapy, supporting consumers with 
smoking cessation, and other primary health care issues  (Pharmacy Guild of Australia, 
2010).   
One systematic review of pharmacists’ role in mental health (Finley, Crismon, & 
Rush, 2003) identified that pharmacists were involved in several aspects of mental health 
medication management including making treatment recommendations, providing education 
to consumers and prescribers, and as providers with prescriptive authority.  These 
interventions were delivered by clinical pharmacists rather than community pharmacists.  
Bell, McLachlan, Aslani, Whitehead and Chen (2005) conducted a systematic review of the  
impact of community-based services delivered by pharmacists and identified four studies 
showing that pharmacist medication reviews may reduce the number of potentially 
inappropriate mental health medications prescribed to older persons.  The review also 
identified three studies showing that adherence to treatment in those commencing 
antidepressants, could be improved by pharmacists providing  medication counselling and 
treatment monitoring (Bell, et al., 2005).  Both of these reviews identified a small number of 
studies which were limited by sample size and study design issues.  
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A recent New Zealand study investigating the community pharmacist’s role in 
meeting medicine-related needs for people with mental illness found that pharmacists need to 
increase consumer focused services, such as medication management (e.g. compliance 
packaging, home delivery) and medicine counselling services that are provided in a proactive 
and individualised manner (Crump et al., 2011).  These services need to be extended to 
include the consumer’s family whenever appropriate.  Participants in this study identified as 
very important (1) the building of effective relationships through adopting a nonjudgmental 
and culturally sensitive manner, (2) respecting consumer privacy, (3) spending more time 
with consumers, and (4) using varied communication techniques.   
Australian studies have also shown community pharmacist interventions to have a 
positive impact on mental health consumer outcomes (Bell, et al., 2007; Crockett, Taylor, 
Grabham, & Stanford, 2006; Healthcare Management Advisors, 2010).  An investigation of 
the potential role of community pharmacists as members of community mental health teams 
(CMHTs), identified many valuable areas of pharmacist contributions, including  advising 
both CMHTs and consumers about the quality use of prescription and non-prescription 
medications (including complementary and alternative medicines), conducting drug 
information presentations, and providing consumers with individualised medication regimen 
review services, reviewing CMHT medication charts, obtaining community pharmacy 
dispensing records and contacting other health care providers (Bell, et al., 2007).  Results 
indicated that the inclusion of community pharmacists in the clinical team was welcomed by 
mental health professionals and consumers.  However, it is important to note that most 
multidisciplinary CMHTs in Australia currently do not include a pharmacist (Bell, et al., 
2007).   
For community pharmacy staff to meet the needs of mental health consumers/carers, 
it is important that they have a sound knowledge base and adequate skills and confidence to 
Mental Health Educational Needs of Pharmacy Staff  12 
 
apply these in practice.  To provide an evidenced based assessment of health professionals’ 
educational needs, the following sections will review the literature regarding methods of 
assessing these areas of knowledge, skills, attitudes and beliefs.  Furthermore, these studies 
focused on the role of the pharmacist.  Pharmacy support staff outnumber pharmacists in 
many community pharmacy settings in Australia and throughout the world and therefore are 
an integral yet under-researched group (Human Capital Alliance, 2008).   
Mental Health Knowledge  
Studies seeking to assess knowledge about mental illness have typically used case 
vignettes requiring participants to recognise problems and identify a plan of action (Caldwell 
& Jorm, 2000; Jorm, et al., 1999; Jorm, Korten, Jacomb, Rodgers, & Pollitt, 1997; O'Reilly, 
Bell, & Chen, 2010; Scheerder, et al., 2008; Scheerder, et al., 2009).  Vignettes based on 
symptoms and diagnostic criteria for mental illness such as schizophrenia and depression 
have been used most often.  These vignettes have been used to assess public (Jorm, et al., 
1999) and health professional knowledge (Caldwell & Jorm, 2000; Jorm, et al., 1997; 
O'Reilly, et al., 2010; Scheerder, et al., 2008; Scheerder, et al., 2009). 
Only one study (O'Reilly, et al., 2010) was identified that investigated the mental 
health literacy of Australian community pharmacists.  In that study, O’Reilly, Bell and Chen 
(2010) explored community pharmacists' (n = 391) knowledge and beliefs about mental 
health treatment and outcomes.  The measure of mental health literacy used was previously 
developed by Jorm and colleagues (1997).  The survey contained a descriptive vignette of a 
person with depression or schizophrenia, for which participants were asked "what, if anything 
is wrong with..." and then asked to rate a series of items as being helpful, harmful or neither.  
O’Reilly and colleagues found that community pharmacists’ had a high level of mental health 
literacy with more pharmacists being able to recognise depression than schizophrenia and that 
general practitioners and clinical psychologists were rated as the most helpful professionals.  
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However, this study had a low response rate (19.5%) and used a survey instrument developed 
for the general population rather than health professionals.   
Despite the effectiveness of the use of case vignettes for knowledge assessment, there 
were no studies identified in the literature that reported using this methodology for anxiety 
disorders in the context of community pharmacy.  Similarly, no studies were located 
exploring the knowledge of pharmacy support staff in regards to mental illness.  
Communication Skills 
Research assessing the communication skills of community pharmacy staff working 
with mental health consumers/carers is sparse.  Studies exploring the mental health consumer 
perspective have identified a wish for greater autonomy in the management of their mental 
illness, including greater involvement in the decision making process (Hamann, Cohen, 
Leucht, Busch, & Kissling, 2005), and increased disclosure about their medication (Crockett, 
et al., 2006; Desplenter, Simoens, & Laekeman, 2006), particularly regarding risks and 
alternative therapies (Tanskanen, et al., 2000).  However, other studies have identified 
consumer dissatisfaction with several aspects of communication, including lack of 
information, and lack of follow-up counselling (Black, Murphy, & Gardner, 2009; Happell, 
Manias, & Roper, 2004; Koo, Krass, & Aslani, 2002).  In their systematic review exploring 
the impact of health professionals providing medicine information to mental health 
consumers, Desplenter, Simoens and Laekeman (2006) report that seven of thirteen studies 
showed an improvement in adherence in the intervention groups.  A combination of written 
and verbal information appeared to have better outcomes than either oral or written 
communication alone.  Knowledge was also found to improve in most studies.  Another 
review assessing the impact of adherence interventions for long-term medication use (not 
specifically mental health) provided by community pharmacists was unable to identify a 
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successful strategy to improve adherence: eight studies showed adherence improvement and 
eight showed no effect (Van Wijk, et al., 2005).   
An Australian study (Healthcare Management Advisors, 2010) demonstrated the 
value of pharmacist communication with mental health consumers (n = 92 pharmacists; 58 in 
intervention, 34 in control group).  The intervention included seeking information about the 
consumers’ experience with their medication, assessment of adherence issues, reinforcing the 
need to take the medication as directed, identifying any potential side effects and possible 
referrals to a general practitioner and face-to-face follow-up.  Consumers reported that they 
found the additional support helpful.  The authors recommended that studies to develop 
techniques for community pharmacists to promote and improve medication adherence were 
needed.   
The effectiveness of communication is difficult to measure, particularly in a 
community pharmacy practice setting.  Scales developed to assess the effectiveness of 
communication include self-reporting inventories of participants’ perceived competence 
(Yeap, Beevi, & Lukman, 2008).  However, these scales may not be reflective of 
effectiveness in real-world practice; for example, self-report can be affected by memory and 
the tendency to give socially desirable responses (Yeap, et al., 2008).  In a study to evaluate 
the effectiveness and barriers to communication between community pharmacists and people 
taking antidepressants, pharmacists rated their communication as more effective than did 
consumers (Gardner, Murphy, Woodman, & Connelly, 2001).  This study highlighted an 
important issue of variation between pharmacist and consumer perceptions of communication 
skills and the effectiveness of pharmacist counselling.  Strategies to improve communication 
should be explored, together with valid and reliable methods for measuring the effectiveness 
of communication.  
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Attitudes and Beliefs  
Public beliefs about, and attitudes towards people with mental illness, have been well 
documented (Angermeyer & Dietrich, 2006; Angermeyer & Matschinger, 2003; Corrigan & 
Watson, 2002; Crisp & Gelder, 2000; Fan, 1999; Jorm, et al., 1999; Kai & Crosland, 2001; 
Kobau, et al., 2010; Link, et al., 1987; Scheerder, et al., 2011; Wahl, 1999, 2011).  Although 
most publications are descriptive in nature, at least one review of population studies 
(Angermeyer & Dietrich, 2006) also included theory-based models of the stigmatisation of 
people with mental illness, analyses of time trends and cross-cultural comparisons, and 
evaluation of anti-stigma campaigns.  In general, the available literature identified that the 
public hold stigmatising, prejudicial, and stereotypical views of mental illness (e.g., Wahl, 
1999; Wahl, 2011).  For example, a report by SANE Australia identified that 73% of people 
surveyed (more than 400 adults) had experienced stigma or discrimination in the previous 12 
months because of their mental illness (SANE Media Centre, 2011).  This is a significant 
finding considering the massive public media campaign over the last five years to address this 
issue.  However, the figure was no different to the 2006 survey that found 74% of people 
experienced stigma or discrimination (SANE Media Centre, 2011).  
Attitudes and beliefs of health care professionals including nurses, psychiatrists, 
psychologists, pharmacists and general practitioners have also been explored.  Studies have 
focused on attitudes and beliefs about people with mental illness (Bryant, Guernsey, Pearce, 
& Hokanson, 1985; Cates, Burton, & Woolley, 2005; Healthcare Management Advisors, 
2010; Jorm, et al., 1999; Kassam, Glozier, Leese, Henderson, & Thornicroft, 2010; Nordt, et 
al., 2006; Phokeo, et al., 2004; Scheerder, et al., 2008; Scheerder, et al., 2009; Scheerder, et 
al., 2011), the treatment of mental illness (Caldwell & Jorm, 2000; Jorm, et al., 1997; Lauber, 
Nordt, Braunschweig, & Rössler, 2006; O'Reilly, et al., 2010; Scheerder, et al., 2011), and 
provision of services to consumers/carers (Black, et al., 2009; Caldwell & Jorm, 2000; Cates, 
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et al., 2005; Crump, et al., 2011; Gardner, et al., 2001; Phokeo, et al., 2004; Scheerder, et al., 
2008).  Attitudes and beliefs have typically been assessed using questionnaires such as the 
Social Distance Scale (SDS, Bell et al., 2010), the Beliefs Towards Mental Illness Scale 
(Hirai & Clum, 2000) and the Depression Physician Belief Scale (McCall, Clarke, & Rowley, 
2002).  Despite the education about mental illness that health care professionals receive 
during their training, in the majority of existing studies, stigmatising attitudes were found, 
which is likely to have a negative impact on their provision of care to this group of 
consumers (Jorm, et al., 1999; Nordt, et al., 2006; Phokeo, et al., 2004; Scheerder, et al., 
2008; Scheerder, et al., 2009; Scheerder, et al., 2011; Volmer, et al., 2008; Wahl, 1999).   
The attitudes and beliefs of community pharmacists have only been specifically 
explored in a small number of studies (Crump, et al., 2011; Healthcare Management 
Advisors, 2010; Maslen, Rees, & Redfern, 1996; O'Reilly, et al., 2010; Phokeo, et al., 2004; 
Scheerder, et al., 2008; Scheerder, et al., 2009).  For example, one Canadian study conducted 
in 2002, explored community pharmacists’ (n = 283 participants; 35.4% response rate) 
interactions with people taking psychiatric medications compared to those taking 
cardiovascular medications (Phokeo, et al.).  Using a 5-point Likert scale ranging from 
strongly agree to strongly disagree, participants were asked to rate their agreement with a 
series of statements in a questionnaire.  The questionnaire contained domains relevant to 
professional interaction: attitude, level of comfort when counselling, barriers to providing 
professional services and counsellor role orientation.  Pharmacists generally endorsed a 
positive attitude towards people using mental health medications, but perceived the lack of 
private space for counselling and inadequate training in mental health as important factors 
limiting their consumer interactions.  The authors found that community pharmacists felt 
uncomfortable discussing symptoms of mental illness and indicated reduced monitoring for 
medication-related problems among mental health consumers when compared with those 
Mental Health Educational Needs of Pharmacy Staff  17 
 
taking cardiovascular medications (Phokeo, et al., 2004).  In another study, Cates, Burton and 
Woolley (2005) investigated the attitudes of pharmacists (n = 187 participants; 42% response 
rate) to mental illness and providing pharmaceutical care to mental health consumers using an 
adapted questionnaire.  Analysis revealed pharmacists generally held positive attitudes to 
mental illness and provision of pharmaceutical care.  However, both Cates et al and Phokeo 
et al studies utilised questionnaires that were not specific to any particular mental disorder, 
but rather considered mental illness in general.   
In contrast, Scheerder and colleagues (Scheerder, et al., 2008; Scheerder, et al., 2009) 
specifically explored community pharmacists’ attitude towards depression.  Scheerder and 
colleagues (2008) surveyed a sample of 200 Belgium community pharmacists (response rate 
34.5%), piloting a modified version of the Depression Attitudes Questionnaire (DAQ, 
Botega, Mann, Blizard, & Wilkinson, 1992) adapted to the unique context of the pharmacist 
(Note: the DAQ was previously developed to measure general practitioner attitudes to 
depression).  Scheerder et al (2008; 2009) also included items derived from the Defeat 
Depression Questionnaire (Priest, Vize, Roberts, Roberts, & Tylee, 1996) in their pilot survey 
instrument.  Statements within this instrument were assessed using a 5-point Likert scale.  
Pharmacists generally had a positive attitude towards depression and people with depression 
but several inaccurate opinions about treatment were observed, for example, the belief that 
patients with depression need to pull themselves together, and that antidepressants change 
one’s personality.  The pharmacist respondents  perceived several barriers to fulfilling their 
role in depression care including: lack of education in mental health issues, lack of time with 
individual consumers, lack of information about the consumer and about their treatment, lack 
of privacy in the pharmacy, and difficulties in communicating with people with depression 
(Scheerder, et al., 2008; Scheerder, et al., 2009).   
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In a subsequent study, Scheerder and colleagues (2011) sought to explore community 
professionals’ (e.g. teachers, police officers, social workers, pharmacists and clergymen; n = 
968), mental health professionals’ (e.g. doctors, and mental health workers; n = 169) and 
nurses’ (n = 1533) attitudes towards depression in nine countries belonging to the European 
Alliance Against Depression.  As well as assessing participants’ attitudes towards training 
programmes, the questionnaire included an assessment of the participants' attitudes towards 
depression, its treatment, perceived causes, preferred treatment options and knowledge of 
depression symptoms using an adapted form of the DAQ.  In summary, the majority of 
professionals agreed that depression was a real disease that could be treated, the most likely 
cause of depression was life events, and the preferred treatment options were contacting a 
doctor and a psychotherapist.  Recognition of depression symptoms was high among all 
participants.  Differences in attitude towards depression in professional groups were 
observed, for example, community professionals and nurses were found to have more 
negative attitudes towards people with depression and towards antidepressants than the 
mental health professionals in the study.  The authors concluded that these differences may 
negatively affect professional collaboration, challenge optimal treatment and stigmatise 
consumers (Scheerder, et al., 2011).   
An Australian study conducted in New South Wales found that pharmacists (n = 391; 
response rate 19.5%) believed that people with mental illness were highly likely to be 
discriminated against by members of the community, and those with schizophrenia more so 
than those with depression (O'Reilly, et al., 2010).  In general, the pharmacist had a negative 
view about long-term outcomes.  We located only one study that explored the attitudes and 
beliefs of community pharmacy staff (including pharmacy support staff), towards mental 
illness including depression, anxiety, bipolar disorder, schizophrenia and substance use 
disorders (Healthcare Management Advisors, 2010).  Participants were asked to rate their 
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alignment with attitudinal statements using a combination of 5-point and 7-point Likert 
scales.  In addition, participants were asked to identify from a list of positive and negative 
traits those that they believed most represented a) people with mental illness and b) their own 
personality.  Lastly, pharmacists (but not pharmacy support staff) completed questions that 
assessed their views about their professional roles and interactions with people with mental 
illness.  Overall, the study revealed that community pharmacy staff held a combination of 
stigmatising and non-stigmatising attitudes and beliefs about mental illness, depending upon 
the mental illness under consideration.  In general, beliefs and attitudes held towards people 
with depression and anxiety disorders were more favourable whilst those held towards people 
with schizophrenia and substance use disorders were less favourable.  People with mental 
illness were considered to possess fewer positive traits and more negative traits than the 
pharmacy participants themselves.  Limitations of the study included a low participation rate 
(n = 32 pharmacists; 22 pharmacy support staff) and the use of the same questions for all 
mental disorders under investigation.   
To summarise, although the Healthcare Management Advisors (2010) and O’Reilly et 
al (2010) studies have contributed to a better understanding of the current knowledge, skills 
and attitudes to mental illness in the community pharmacy practice environment, both studies 
have limited generalizability and used survey questionnaires which had not previously been 
tested with community pharmacy staff.  Furthermore only the Health Care Management study 
(2010) included pharmacy support staff.  A larger and representative study investigating the 
knowledge, skills, attitudes and beliefs of the Australian community pharmacy workforce is 
required to inform the development of an educational package which will equip pharmacists 
and pharmacy support staff to engage confidently with mental health consumers/carers.   
Conclusion 
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Critical evaluation of the existing literature indicates that the development of an 
educational package for community pharmacy staff to meet the needs of mental health 
consumers/carers must be informed through a systematic and evidence-based identification of 
knowledge gaps of community pharmacy staff alongside an exploration of the needs and 
expectations of mental health consumers/carers.  Such a needs assessment should also include 
other stakeholders such as consumer and carer organisation representatives, and other health 
professionals involved in the provision of mental health care as a collaborative approach has 
been shown to optimise consumer outcomes.  The assessment of community pharmacy staff 
knowledge, skills and attitudes should be based on validated tools, and should include both 
pharmacist and pharmacy support staff; however, reliable instruments must be tailored for 
this purpose.  In the context of the primary care setting these tools should focus on high 
prevalence disorders such as depression and anxiety.  For the purpose of a large-scale 
longitudinal project focusing on these issues, development of specific measures seems 
justified. 
In particular, this review has revealed that areas of training needs include targeting 
stigma and discrimination, enhancing knowledge, and developing skills and strategies to 
improve confidence and communication skills for pharmacy staff.  Including pharmacy 
support staff in this training is imperative as they are often the first point of contact for 
consumers.  These outcomes will be the goal of the next stage in the longitudinal research 
program.  
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